0001209191-23-004237.txt : 20230120 0001209191-23-004237.hdr.sgml : 20230120 20230120161433 ACCESSION NUMBER: 0001209191-23-004237 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230119 FILED AS OF DATE: 20230120 DATE AS OF CHANGE: 20230120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MENDLEIN JOHN CENTRAL INDEX KEY: 0001238362 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36076 FILM NUMBER: 23541146 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FATE THERAPEUTICS INC CENTRAL INDEX KEY: 0001434316 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 651311552 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12278 SCRIPPS SUMMIT DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92131 BUSINESS PHONE: 858.875.1803 MAIL ADDRESS: STREET 1: 12278 SCRIPPS SUMMIT DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92131 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-19 0 0001434316 FATE THERAPEUTICS INC FATE 0001238362 MENDLEIN JOHN C/O FATE THERAPEUTICS, INC. 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 1 0 0 0 Common Stock 2023-01-19 4 M 0 28461 1.37 A 311231 D Stock Option (Right to Buy) 1.37 2023-01-19 4 M 0 28461 0.00 A 2023-02-06 Common Stock 28461 0 D This stock option is fully vested and exercisable. /s/ Cindy Tahl, as Attorney-in-Fact 2023-01-20